our therapeutic areas
We are apharmaceutical company focused in therespiratory area. Our mission is the research, development and production of unique and innovative pharmaceutical products. We specialize in the treatment of: Rhinosinusitis, Otitis Media with Effusion (OME) and Recurrent Respiratory Infections (IRR).
The products of our pharmaceutical company,
unique in the market and patented.
We have several innovative products already available on the market, and others in research, development, or clinical trials. The drugs already available are indicated in respiratory diseases, especially for: Rhinosinusitis, Otitis Media with Effusion, and Recurrent Respiratory Infections.
You are a Physicianor a Pharmacist? Log in to the private area and discover the benefits reserved for you!
CILIACELL
THE ONLY PRODUCT
ON THE MARKET.
CAPABLE OF ACTING
EFFECTIVELY
ON THE REAL CAUSES
OF RHINOSINUSITIS
There are many drugs on the market used to treat rhinosinusitis, which almost always act only on symptoms, except for antibiotics that act on bacterial infections but are not effective against viral infections (which account for 85 percent of the etiological agents responsible for rhinosinusitis) and fungal infections.
A specific product for the treatment of rhinosinusitis should act simultaneously on the three clinical characterizations of the same rhinopathies, namely: edema of the naso-sinus mucosa, slowing or even stopping of ciliary mobility and motility, and accumulation of muco-purulent secretions in the naso-sinus district and auditory tubes.
Today, there is a product on the market specifically for rhinosinusitis characterized by precisely all three of the above clinical manifestations. This product, which has been developed and patented by Italian researchers as well as tested in several clinical studies of national and international significance, is marketed under the brand name CiliaCell. Theeffectiveness of clinical healing by such a medical device, is more than 90%.
CILIACELL
THE ONLY PRODUCT ON THE MARKET
CAPABLE OF ACTING EFFECTIVELY
ON THE REAL CAUSES OF RHINOSINUSITIS!
There are many drugs on the market used to treat rhinosinusitis, which almost always act only on symptoms, except for antibiotics that act on bacterial infections but are not effective against viral infections (which account for 85 percent of the etiological agents responsible for rhinosinusitis) and fungal infections.
A specific product for the treatment of rhinosinusitis should act simultaneously on the three clinical characterizations of the same rhinopathies, namely: edema of the naso-sinus mucosa, slowing or even stopping of ciliary mobility and motility, and accumulation of muco-purulent secretions in the naso-sinus district and auditory tubes.
Ciliacell is the only product specifically designed to effectively treat rhinosinusitis characterized by the above clinical manifestations, namely:
Edema of the naso-sinus mucosa, slowing or stopping of ciliary mobility and motility, accumulation of muco-purulent secretions in the naso-sinus district and auditory tubes.
Ciliacell is a patent-protected product of Nevia Biotech and has been tested in several internationally prominent clinical trials.
Thedemonstrated clinical healing efficacy is more than 90%.
Discover the Group
NEVIA |
BIOTECH |
We are a Swiss-Italian corporate group with offices in Lugano (Switzerland) and Montella AV (Italy), engaged in Research, Development, Production and Commercialization of innovative pharmaceutical products in the respiratory field, particularly for rhinosinusitis.
Our strength is to possess someunique pharmaceutical products, characterized by efficacy and safety in their use, all proven with relevant clinical studies.
RESEARCH AND DEVELOPMENT |
Innovative products already on the market, and others under development or in clinical trials.
SEARCH
AND DEVELOPMENT. |
Innovative products already on the market, and others under development or in clinical trials.
Research and Development
The beating heart of Nevia Biotech
The research and development area is the beating heart of our pharmaceutical company. Almost all of the products on the market, in fact, come from the company’s research and development, focused mainly on creating new drugs in rheumatology and neuropsychiatry, as well as, of course, in the respiratory field.
At present, Nevia Biotech has some very important research and development projects, such as:
- Development of a new pharmaceutical product for the treatment of non-allergic cell-mediated rhinitis Nares, Narma, Narne, Naresma(the only product in the world specifically for the treatment of these nosological entities)
- Development of new drugs for the treatment of pre-eclampsia, fibromyalgia and A.D.H.D.
Clinical Research
CiliaCell, a unique product for rhinosinusitis and otitis
The most important products in our company list at the moment are those of the CiliaCell line , which are specific and unique in the world for the treatment of rhinosinusitis corniche and otitis media effusive, both in adults and pediatric age.
Several clinical studies have already been conducted for these products and published in top scientific journals in the field.
The Research and Development Pipeline
of our pharmaceutical company.
The research and development pipeline of our pharmaceutical company includes several therapeutic areas, such as:
Respiratory, Rheumatology, Child Neuropsychiatry.
Non-allergic vasomotor rhinitis, among chronic rhinopathies, represents an area…
Attention Deficit Disorder with Hyperactivity Disorder (ADHD, an acronym for the English…
The word fibromyalgia (FM) comes from the Latin fibre, which stands for the tissues…
TRADE
WHOLESALE.
OF DRUGS.
Nevia Biotech is a pharmaceutical company licensed by Swissemedic for:
- Imports of medicines
- Wholesale of medicines
- Export of medicines
- Foreign trade in medicines
We are able to source and supply any kind of drugs globally, including: drugs lacking in different countries, orphan drugs, oncology drugs, vaccines, chemotherapeutics, etc.
DOWNLOAD DRUG LIST
By way of example, but not limited to, the list of drugs we can provide: see drug list
Stay Updated!
Sign up for the newsletter.
Sign up for the Newsletter, receive our offers, pharmaceutical news and promotions from Nevia Biotech before anyone else.